Form 8-K - Current report:
SEC Accession No. 0001193125-25-047882
Filing Date
2025-03-06
Accepted
2025-03-06 08:05:40
Documents
14
Period of Report
2025-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d940367d8k.htm   iXBRL 8-K 25179
2 EX-99.1 d940367dex991.htm EX-99.1 90511
  Complete submission text file 0001193125-25-047882.txt   256326

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA phat-20250306.xsd EX-101.SCH 2867
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20250306_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20250306_pre.xml EX-101.PRE 11718
16 EXTRACTED XBRL INSTANCE DOCUMENT d940367d8k_htm.xml XML 3775
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 25713665
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)